Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$12.46 - $19.98 $74,485 - $119,440
-5,978 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$11.0 - $18.26 $22,649 - $37,597
2,059 Added 52.54%
5,978 $101,000
Q1 2020

May 15, 2020

SELL
$10.11 - $14.04 $60,296 - $83,734
-5,964 Reduced 60.35%
3,919 $47,000
Q4 2019

Feb 14, 2020

BUY
$12.06 - $16.96 $119,188 - $167,615
9,883 New
9,883 $120,000
Q3 2019

Nov 14, 2019

SELL
$10.41 - $14.66 $42,681 - $60,106
-4,100 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$9.78 - $12.76 $24,450 - $31,900
2,500 Added 156.25%
4,100 $46,000
Q1 2019

May 15, 2019

SELL
$10.03 - $15.71 $761,337 - $1.19 Million
-75,906 Reduced 97.94%
1,600 $19,000
Q4 2018

Feb 14, 2019

BUY
$11.29 - $17.19 $234,120 - $356,469
20,737 Added 36.53%
77,506 $1.04 Million
Q3 2018

Nov 14, 2018

SELL
$12.27 - $15.65 $12,270 - $15,650
-1,000 Reduced 1.73%
56,769 $796,000
Q2 2018

Aug 14, 2018

BUY
$15.3 - $19.69 $15,300 - $19,690
1,000 Added 1.76%
57,769 $908,000
Q1 2018

May 15, 2018

BUY
$14.59 - $25.5 $72,483 - $126,684
4,968 Added 9.59%
56,769 $934,000
Q4 2017

Feb 14, 2018

BUY
$15.77 - $20.72 $306,758 - $403,045
19,452 Added 60.13%
51,801 $936,000
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $397,892 - $624,335
32,349
32,349 $624,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.82B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.